Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Hypertension

  Free Subscription


13.03.2023

1 Am J Hypertens
1 Am J Med
2 Ann Vasc Surg
2 Clin Exp Hypertens
1 Curr Opin Nephrol Hypertens
1 Eur Heart J
3 Hypertension
1 J Am Soc Nephrol
1 J Clin Endocrinol Metab
1 J Hum Hypertens
11 J Hypertens
2 N Engl J Med
11 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Hypertens

  1. SIDDIQUI M, Muntner P
    The need to assess adherence in apparent treatment resistant hypertension.
    Am J Hypertens. 2023 Mar 9:hpad024. doi: 10.1093.
    PubMed        


    Am J Med

  2. FILIPPONE EJ, Foy AJ, Naccarelli GV
    Controversies in Hypertension III: Dipping, Nocturnal Hypertension, and the Morning Surge.
    Am J Med. 2023 Mar 7:S0002-9343(23)00160-2. doi: 10.1016/j.amjmed.2023.
    PubMed         Abstract available


    Ann Vasc Surg

  3. SUH D, Hatcher VH, Muhonen J, Katz D, et al
    Renal Artery Stenosis due to Entrapment.
    Ann Vasc Surg. 2022;87:31-39.
    PubMed         Abstract available

  4. CHANG H, Gelb BE, Stewart ZA, Lonze BE, et al
    Safety and Efficacy of Drug Eluting Stents for Treatment of Transplant Renal Artery Stenosis.
    Ann Vasc Surg. 2022;87:245-253.
    PubMed         Abstract available


    Clin Exp Hypertens

  5. ZHANG M, Zeng Q, Zhou S, Zhu G, et al
    Mendelian randomization study on causal association of IL-6 signaling with pulmonary arterial hypertension.
    Clin Exp Hypertens. 2023;45:2183963.
    PubMed         Abstract available

  6. LIN M, Wang X, Ye B, Zhang J, et al
    External counterpulsation stimulation combined with acupuncture for vascular endothelial function in patients with hypertension: A randomized pilot trial.
    Clin Exp Hypertens. 2023;45:2181355.
    PubMed         Abstract available


    Curr Opin Nephrol Hypertens

  7. HUNDEMER GL, Kline GA, Leung AA
    How common is primary aldosteronism?
    Curr Opin Nephrol Hypertens. 2021;30:353-360.
    PubMed         Abstract available


    Eur Heart J

  8. HAXHA S, Halili A, Malmborg M, Pedersen-Bjergaard U, et al
    Type 2 diabetes mellitus and higher rate of complete atrioventricular block: a Danish Nationwide Registry.
    Eur Heart J. 2022 Nov 26:ehac662. doi: 10.1093.
    PubMed         Abstract available


    Hypertension

  9. WANG R
    Roles of Hydrogen Sulfide in Hypertension Development and Its Complications: What, So What, Now What.
    Hypertension. 2023 Mar 7. doi: 10.1161/HYPERTENSIONAHA.122.19456.
    PubMed         Abstract available

  10. BRYANT KB, Rao AS, Cohen LP, DanDan N, et al
    Effectiveness and Cost-Effectiveness of Team-Based Care for Hypertension: A Meta-Analysis and Simulation Study.
    Hypertension. 2023 Mar 8. doi: 10.1161/HYPERTENSIONAHA.122.20292.
    PubMed         Abstract available

  11. SHI Y, Liu J, Zhang R, Zhang M, et al
    Targeting Endothelial ENO1 (Enolase) -PI3K-Akt-mTOR Axis Alleviates Hypoxic Pulmonary Hypertension.
    Hypertension. 2023 Mar 8. doi: 10.1161/HYPERTENSIONAHA.122.19857.
    PubMed         Abstract available


    J Am Soc Nephrol

  12. KU E, McCulloch CE, Inker LA, Tighiouart H, et al
    Intensive BP Control in Patients with CKD and Risk for Adverse Outcomes.
    J Am Soc Nephrol. 2023;34:385-393.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  13. ALLOQI TAHIRBEGOLLI I, Tahirbegolli B, Sen S, Sayin B, et al
    Evaluation of Stress Response in Middle Age Male Diabetic Hypertensive Patients.
    J Clin Endocrinol Metab. 2023 Mar 6:dgad122. doi: 10.1210.
    PubMed         Abstract available


    J Hum Hypertens

  14. BABAGOLI MA, Chen YH, Chakma N, Islam MS, et al
    Association of socio-demographic characteristics with hypertension awareness, treatment, and control in Bangladesh.
    J Hum Hypertens. 2023 Mar 7. doi: 10.1038/s41371-023-00815.
    PubMed         Abstract available


    J Hypertens

  15. CARNAGARIN R, Nolde JM, Yang J, Marques FZ, et al
    Stagnating rates of blood pressure control in Australia: insights from opportunistic screening of 10 046 participants of the May Measurement Month campaigns.
    J Hypertens. 2023;41:632-637.
    PubMed         Abstract available

  16. GALLAGHER BD, Windish DM
    State of ambulatory hypertension education in U.S. internal medicine residency programs: a needs assessment survey.
    J Hypertens. 2023;41:678-679.
    PubMed        

  17. WOODS AP, Feeney T, Papageorge MV, de Geus SWL, et al
    Addressing diagnostic inertia following incidental adrenal mass discovery in patients with hypertension.
    J Hypertens. 2023;41:680-682.
    PubMed        

  18. KUMAR SM, Anandraj J, Sivanatham P, Essakky S, et al
    Control status of hypertension in India: systematic review and meta-analysis.
    J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003381.
    PubMed         Abstract available

  19. UKOHA-KALU BO, Adibe MO, Ukwe CV
    A qualitative study of patients' and carers' perspectives on factors influencing access to hypertension care and compliance with treatment in Nigeria.
    J Hypertens. 2023 Mar 3. doi: 10.1097/HJH.0000000000003409.
    PubMed         Abstract available

  20. XUE CC, Li C, Hu JF, Wei CC, et al
    Retinal vessel caliber and tortuosity and prediction of 5-year incidence of hypertension.
    J Hypertens. 2023 Mar 3. doi: 10.1097/HJH.0000000000003406.
    PubMed         Abstract available

  21. WU S, Tian X, Chen S, Zhang Y, et al
    Arterial stiffness and blood pressure in treated hypertension: a longitudinal study.
    J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003400.
    PubMed         Abstract available

  22. GAO Y, Liu B, Guo X, Nie J, et al
    Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension.
    J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003401.
    PubMed         Abstract available

  23. LI D, Zhang S, Cao F, Han J, et al
    The sustainable antihypertensive and target organ damage protective effect of transcranial focused ultrasound stimulation in spontaneously hypertensive rats.
    J Hypertens. 2023 Mar 3. doi: 10.1097/HJH.0000000000003407.
    PubMed         Abstract available

  24. XIONG S, Yin S, Deng W, Zhao Y, et al
    Predictive value of liver fibrosis scores in cardiovascular diseases among hypertensive population.
    J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003394.
    PubMed         Abstract available

  25. GOULAS I, Evripidou K, Doundoulakis I, Kollios K, et al
    Prevalence of masked hypertension and its association with left ventricular hypertrophy in children and young adults with chronic kidney disease: a systematic review and meta-analysis.
    J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003402.
    PubMed         Abstract available


    N Engl J Med

  26. HOEPER MM, Badesch DB, Ghofrani HA, Gibbs JSR, et al
    Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.
    N Engl J Med. 2023 Mar 6. doi: 10.1056/NEJMoa2213558.
    PubMed         Abstract available

  27. TAICHMAN DB, Leopold JA, Elliott G
    Continued Progress in Therapy for Pulmonary Arterial Hypertension.
    N Engl J Med. 2023 Mar 6. doi: 10.1056/NEJMe2300324.
    PubMed        


    PLoS One

  28. DIECI M, Llibre-Rodriguez JJ, Acosta D, Dow WH, et al
    Cuba's cardiovascular risk factors: International comparison of levels and education gradients.
    PLoS One. 2021;16:e0247831.
    PubMed         Abstract available

  29. HEGEWALD J, Romero Starke K, Garthus-Niegel S, Schulz A, et al
    Work-life conflict and cardiovascular health: 5-year follow-up of the Gutenberg Health Study.
    PLoS One. 2021;16:e0251260.
    PubMed         Abstract available

  30. HANIF AAM, Hasan M, Khan MSA, Hossain MM, et al
    Ten-years cardiovascular risk among Bangladeshi population using non-laboratory-based risk chart of the World Health Organization: Findings from a nationally representative survey.
    PLoS One. 2021;16:e0251967.
    PubMed         Abstract available

  31. HEDERMANN G, Hedley PL, Thagaard IN, Krebs L, et al
    Maternal obesity and metabolic disorders associate with congenital heart defects in the offspring: A systematic review.
    PLoS One. 2021;16:e0252343.
    PubMed         Abstract available

  32. KIM J, Kim JH, Lee HS, Suh SH, et al
    Association between longitudinal blood pressure and prognosis after treatment of cerebral aneurysm: A nationwide population-based cohort study.
    PLoS One. 2021;16:e0252042.
    PubMed         Abstract available

  33. CHEZA A, Tlou B, Zhou DT
    Incidence of non-communicable diseases (NCDs) in HIV patients on ART in a developing country: Case of Zimbabwe's Chitungwiza Central Hospital-A retrospective cohort study (2010-2019).
    PLoS One. 2021;16:e0252180.
    PubMed         Abstract available

  34. SHARP G, Carpiano RM
    Neighborhood social organization exposures and racial/ethnic disparities in hypertension risk in Los Angeles.
    PLoS One. 2023;18:e0282648.
    PubMed         Abstract available

  35. MUMENA WA, Hammouda SA, Aljohani RM, Alzahrani AM, et al
    Prevalence and determinants of undiagnosed hypertension in the Western region of Saudi Arabia.
    PLoS One. 2023;18:e0280844.
    PubMed         Abstract available

  36. KRONBERGER C, Mousavi RA, Ozturk B, Willixhofer R, et al
    Functional capacity testing in patients with pulmonary hypertension (PH) using the one-minute sit-to-stand test (1-min STST).
    PLoS One. 2023;18:e0282697.
    PubMed         Abstract available

  37. LEE JG, Joo SJ, Kim SY, Choi JH, et al
    Impact of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers on clinical outcomes in hypertensive patients with acute myocardial infarction.
    PLoS One. 2023;18:e0281460.
    PubMed         Abstract available

  38. YANG Q, Fan W, Lai B, Liao B, et al
    lncRNA-TCONS_00008552 expression in patients with pulmonary arterial hypertension due to congenital heart disease.
    PLoS One. 2023;18:e0281061.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: